Xofigo® - radium Ra 223 dichloride injection

Important Safety Information

Do not take Xofigo if you are pregnant or may become pregnant. Xofigo can harm your unborn baby. Women who are pregnant or
who may become pregnant should not come in contact with Xofigo without protection, such as gloves. Continue reading below

90% of advanced prostate cancer spreads to the bones

Help your doctor evaluate whether your bone metastases have become symptomatic.

Bone cancer image

Xofigo is a treatment that Audio icon (zo-FEEG-oh) :

  • Helps extend life by more than 30% (14.9 months in Xofigo-treated men vs 11.3 months in placebo-treated men, in an updated analysis)
  • Goes to the bone, giving off strong energy that kills cancer cells, but does limited damage to nearby healthy cells
  • Can be absorbed by organs other than bone, primarily the bone marrow and digestive system, which can result in side effects in those healthy tissues
Download the
Xofigo Fact Sheet

$0 Copay now available for eligible private commercially
insured patients through Xofigo® Access Services
Click here to learn more.

A new level of Financial Support for privately insured Xofigo patients

*Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, e.g., co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payors of any benefits they receive and the value of this program, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Patients enrolled in Bayer’s Patient Assistance Program are not eligible. Bayer may determine eligibility, monitor participation, equitably distribute product and modify or discontinue any aspect of the Xofigo Access Services at any time, including but not limited to this commercial co-pay assistance program. Only patients not currently enrolled in the Xofigo Access Services are eligible; current participants may enroll upon their annual renewal date. For important risk and use information, please see the Patient Prescribing Information or the full Prescribing Information.

Continue to the full site

WHEN YOUR DOCTOR PRESCRIBES XOFIGO®

$0 Copay* Now Available for eligible privately insured patients

Contact Xofigo® Access Services
by phone: 1-855-6XOFIGO
(1-855-696-3446)

About Xofigo

Xofigo could be an important part of your treatment plan.

Preparing for Treatment

Xofigo has special administration considerations.

Access & Support

Xofigo Access Services is here to help.

*Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, e.g., co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payors of any benefits they receive and the value of this program, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Patients enrolled in Bayer’s Patient Assistance Program are not eligible. Bayer may determine eligibility, monitor participation, equitably distribute product and modify or discontinue any aspect of the Xofigo Access Services at any time, including but not limited to this commercial co-pay assistance program. Only patients not currently enrolled in the Xofigo Access Services are eligible; current participants may enroll upon their annual renewal date. For important risk and use information, please see the Patient Prescribing Information or the full Prescribing Information.

Indication

Xofigo® (radium Ra 223 dichloride) injection is used to treat prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to your bones with symptoms, but not to other parts of your body. The medical term for this condition is metastatic castration-resistant prostate cancer, or mCRPC.

Important Safety Information

Do not take Xofigo if you are pregnant or may become pregnant. Xofigo can harm your unborn baby. Women who are pregnant or who may become pregnant should not come in contact with Xofigo without protection, such as gloves.

Before taking Xofigo, tell your healthcare provider if you:

While you are on Xofigo:

The most common side effects of Xofigo include:

Tell your healthcare provider if you have any side effects that bother you or do not go away.

You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call
1-800-FDA-1088. For important risk and use information about Xofigo, please see the Full Prescribing Information.